LINCOCIN 500 MG
LINCOMYCIN (LINCOMYCIN HYDROCHLORIDE) : 500 MG · DIN 00030589 · PFIZER CANADA ULC
Health Canada status: CANCELLED POST MARKET
What is LINCOCIN?
LINCOCIN 500 MG contains LINCOMYCIN (LINCOMYCIN HYDROCHLORIDE) : 500 MG. It is listed in the Health Canada Drug Product Database under DIN 00030589, held by PFIZER CANADA ULC, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 02-Aug-2006. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is LINCOCIN used for?
LINCOCIN (lincomycin hydrochloride) is indicated in the treatment of serious infections due to sensitive gram positive organisms (staphylococci, including penicillinase-producing staphylococci, streptococci and pneumococci) when the patient is intolerant of, or the organism resistant to other appropriate antibiotics. LINCOCIN is indicated in the treatment of osteomyelitis, when the causative organism has been found to be sensitive to this antibiotic.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 00030589 |
|---|---|
| Brand name | LINCOCIN |
| Generic / active ingredient | LINCOMYCIN (LINCOMYCIN HYDROCHLORIDE) : 500 MG |
| Manufacturer | PFIZER CANADA ULC |
| Strength | 500 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | J01FF02 LINCOMYCIN |
| AHFS class | 08:12.28.20 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 02-Aug-2006 |
| Original market date | 1964-12-31 00:00:00 |
How is it administered?
IM: 600mg every 12-24h (adults), 10mg/kg every 12-24h (children >1 month). IV: 600mg-1g every 8-12h infused over 30-120 mins. Oral: 500mg capsules.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store at room temperature (15 -30 ºC), protect from light.
How is it supplied?
Sterile Solution - 2 mL; Capsules - bottles of 100 capsules
Contraindications
Hypersensitivity to lincomycin, clindamycin, or any component; known pre-existing monilial infections; newborn infants.
Warnings and precautions
Clostridium difficile-associated disease (CDAD) ranging from mild diarrhea to fatal colitis. Do not administer undiluted IV (risk of cardiopulmonary arrest). Contains benzyl alcohol.
What can be used instead?
Other Canadian products sharing ATC code J01FF02 LINCOMYCIN. 0 of 2 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| LINCOCIN | 300 MG | SOLUTION | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 00030732 |
Who else supplies LINCOMYCIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. LINCOMYCIN appears in 11 registered pack listings across 8 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.